Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ocrevus. Always confirm against the full prescribing information.
100 interactions
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Ocrelizumab.
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Ocrelizumab.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Ocrelizumab.
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Ocrelizumab.
Level 2 evidence
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Ocrelizumab.
Level 1 evidence
Aducanumab
The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Aducanumab.
Level 2 evidence
Alirocumab
The risk or severity of adverse effects can be increased when Alirocumab is combined with Ocrelizumab.
Level 2 evidence
Allogeneic processed thymus tissue
The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Ocrelizumab.
Level 2 evidence
Amivantamab
The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Amivantamab.
Level 2 evidence
Ansuvimab
The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Ansuvimab.
Level 2 evidence
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ocrelizumab.
Level 1 evidence
Enter your NPI to unlock 67 major interactions for Ocrevus
Ocrevus (Ocrelizumab) has 380 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ocrevus (Ocrelizumab) has 226 major, 34 moderate, and 120 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ocrevus. Always confirm against the full prescribing information.